Hepatoblastomas in Oman

Unveiling success

Fatma Rabah, Nagwa El-Banna, Dipali Bhuyan, Ibrahim Al-Ghaithi, Mohamed Al-Hinai, Amal Al-Sabahi, Nawal Al-Mashaikhi, Ismail Beshlawi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: Primary malignant liver tumours account for more than 1% of all paediatric malignancies, with the most common form being hepatoblastomas (HB). Such malignancies among Arab populations have rarely been addressed in the literature. Using data from Oman’s sole national referral centre for childhood solid malignancies, this study aimed to present the nationwide Omani experience with HB over the past 21 years. Methods: This retrospective study reviewed the medical records of all children with HB who were managed in the Royal Hospital, Muscat, Oman, between January 1991 and April 2012. Clinical, radiological and laboratory characteristics were examined as well as treatments and outcomes. Results: During the study period, 15 patients with HB were treated. Of these, 10 have survived to date. Nine of the survivors were no longer receiving treatment and one patient still had the disease but was in a stable condition. Of the remaining five patients, three did not survive and two were lost to follow-up. The survival rate among patients who completed therapy was 91%. Conclusion: HB has an excellent prognosis in Oman. The main obstacle to improving outcomes among Omani patients is non-compliance with therapy.

Original languageEnglish
Pages (from-to)e85-e90
JournalSultan Qaboos University Medical Journal
Volume15
Issue number1
Publication statusPublished - 2015

Fingerprint

Oman
Hepatoblastoma
Neoplasms
Lost to Follow-Up
Patient Compliance
Medical Records
Survivors
Therapeutics
Referral and Consultation
Survival Rate
Retrospective Studies
Pediatrics
Liver
Population

Keywords

  • Hepatic Cancer
  • Hepatoblastoma
  • Neoadjuvant Therapy
  • Oman

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rabah, F., El-Banna, N., Bhuyan, D., Al-Ghaithi, I., Al-Hinai, M., Al-Sabahi, A., ... Beshlawi, I. (2015). Hepatoblastomas in Oman: Unveiling success. Sultan Qaboos University Medical Journal, 15(1), e85-e90.

Hepatoblastomas in Oman : Unveiling success. / Rabah, Fatma; El-Banna, Nagwa; Bhuyan, Dipali; Al-Ghaithi, Ibrahim; Al-Hinai, Mohamed; Al-Sabahi, Amal; Al-Mashaikhi, Nawal; Beshlawi, Ismail.

In: Sultan Qaboos University Medical Journal, Vol. 15, No. 1, 2015, p. e85-e90.

Research output: Contribution to journalArticle

Rabah, F, El-Banna, N, Bhuyan, D, Al-Ghaithi, I, Al-Hinai, M, Al-Sabahi, A, Al-Mashaikhi, N & Beshlawi, I 2015, 'Hepatoblastomas in Oman: Unveiling success', Sultan Qaboos University Medical Journal, vol. 15, no. 1, pp. e85-e90.
Rabah F, El-Banna N, Bhuyan D, Al-Ghaithi I, Al-Hinai M, Al-Sabahi A et al. Hepatoblastomas in Oman: Unveiling success. Sultan Qaboos University Medical Journal. 2015;15(1):e85-e90.
Rabah, Fatma ; El-Banna, Nagwa ; Bhuyan, Dipali ; Al-Ghaithi, Ibrahim ; Al-Hinai, Mohamed ; Al-Sabahi, Amal ; Al-Mashaikhi, Nawal ; Beshlawi, Ismail. / Hepatoblastomas in Oman : Unveiling success. In: Sultan Qaboos University Medical Journal. 2015 ; Vol. 15, No. 1. pp. e85-e90.
@article{77d3b7f75bf14f7c8f8a04f1576d4a60,
title = "Hepatoblastomas in Oman: Unveiling success",
abstract = "Objectives: Primary malignant liver tumours account for more than 1{\%} of all paediatric malignancies, with the most common form being hepatoblastomas (HB). Such malignancies among Arab populations have rarely been addressed in the literature. Using data from Oman’s sole national referral centre for childhood solid malignancies, this study aimed to present the nationwide Omani experience with HB over the past 21 years. Methods: This retrospective study reviewed the medical records of all children with HB who were managed in the Royal Hospital, Muscat, Oman, between January 1991 and April 2012. Clinical, radiological and laboratory characteristics were examined as well as treatments and outcomes. Results: During the study period, 15 patients with HB were treated. Of these, 10 have survived to date. Nine of the survivors were no longer receiving treatment and one patient still had the disease but was in a stable condition. Of the remaining five patients, three did not survive and two were lost to follow-up. The survival rate among patients who completed therapy was 91{\%}. Conclusion: HB has an excellent prognosis in Oman. The main obstacle to improving outcomes among Omani patients is non-compliance with therapy.",
keywords = "Hepatic Cancer, Hepatoblastoma, Neoadjuvant Therapy, Oman",
author = "Fatma Rabah and Nagwa El-Banna and Dipali Bhuyan and Ibrahim Al-Ghaithi and Mohamed Al-Hinai and Amal Al-Sabahi and Nawal Al-Mashaikhi and Ismail Beshlawi",
year = "2015",
language = "English",
volume = "15",
pages = "e85--e90",
journal = "Sultan Qaboos University Medical Journal",
issn = "2075-051X",
publisher = "Sultan Qaboos University",
number = "1",

}

TY - JOUR

T1 - Hepatoblastomas in Oman

T2 - Unveiling success

AU - Rabah, Fatma

AU - El-Banna, Nagwa

AU - Bhuyan, Dipali

AU - Al-Ghaithi, Ibrahim

AU - Al-Hinai, Mohamed

AU - Al-Sabahi, Amal

AU - Al-Mashaikhi, Nawal

AU - Beshlawi, Ismail

PY - 2015

Y1 - 2015

N2 - Objectives: Primary malignant liver tumours account for more than 1% of all paediatric malignancies, with the most common form being hepatoblastomas (HB). Such malignancies among Arab populations have rarely been addressed in the literature. Using data from Oman’s sole national referral centre for childhood solid malignancies, this study aimed to present the nationwide Omani experience with HB over the past 21 years. Methods: This retrospective study reviewed the medical records of all children with HB who were managed in the Royal Hospital, Muscat, Oman, between January 1991 and April 2012. Clinical, radiological and laboratory characteristics were examined as well as treatments and outcomes. Results: During the study period, 15 patients with HB were treated. Of these, 10 have survived to date. Nine of the survivors were no longer receiving treatment and one patient still had the disease but was in a stable condition. Of the remaining five patients, three did not survive and two were lost to follow-up. The survival rate among patients who completed therapy was 91%. Conclusion: HB has an excellent prognosis in Oman. The main obstacle to improving outcomes among Omani patients is non-compliance with therapy.

AB - Objectives: Primary malignant liver tumours account for more than 1% of all paediatric malignancies, with the most common form being hepatoblastomas (HB). Such malignancies among Arab populations have rarely been addressed in the literature. Using data from Oman’s sole national referral centre for childhood solid malignancies, this study aimed to present the nationwide Omani experience with HB over the past 21 years. Methods: This retrospective study reviewed the medical records of all children with HB who were managed in the Royal Hospital, Muscat, Oman, between January 1991 and April 2012. Clinical, radiological and laboratory characteristics were examined as well as treatments and outcomes. Results: During the study period, 15 patients with HB were treated. Of these, 10 have survived to date. Nine of the survivors were no longer receiving treatment and one patient still had the disease but was in a stable condition. Of the remaining five patients, three did not survive and two were lost to follow-up. The survival rate among patients who completed therapy was 91%. Conclusion: HB has an excellent prognosis in Oman. The main obstacle to improving outcomes among Omani patients is non-compliance with therapy.

KW - Hepatic Cancer

KW - Hepatoblastoma

KW - Neoadjuvant Therapy

KW - Oman

UR - http://www.scopus.com/inward/record.url?scp=84922662128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922662128&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - e85-e90

JO - Sultan Qaboos University Medical Journal

JF - Sultan Qaboos University Medical Journal

SN - 2075-051X

IS - 1

ER -